BGAI
HAE icon

Bruce G. Allen Investments’s Haemonetics HAE Stock Holding History

Bruce G. Allen Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Hold
15
– – ﹤0.01% 801
2026
Q1 		$845 Buy
15
+5
+50% +$326 ﹤0.01% 861
2025
Q4 		$802 Sell
10
-3
-23% -$202 ﹤0.01% 878
2025
Q3 		$634 Hold
13
– – ﹤0.01% 920
2025
Q2 		$970 Buy
13
+1
+8% +$66 ﹤0.01% 832
2025
Q1 		$763 Hold
12
– – ﹤0.01% 858
2024
Q4 		$937 Buy
12
+2
+20% +$161 ﹤0.01% 834
2024
Q3 		$804 Buy
+10
New +$808 ﹤0.01% 865

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bruce G. Allen Investments's HAE Position: Q2 2026 in Review

Bruce G. Allen Investments held its Haemonetics (HAE) position steady in Q2 2026 at 15 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Bruce G. Allen Investments first reported a position in HAE in Q3 2024 and has held it in 8 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Bruce G. Allen Investments held 15 shares of Haemonetics worth $1.13K as of Q2 2026.
  • Bruce G. Allen Investments left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #801 holding.
  • Bruce G. Allen Investments first reported a position in Haemonetics in Q3 2024 and has held it in 8 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.